VRDN

NASDAQ · Biotechnology

Viridian Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$28.49

-0.06 (-0.21%)

As of Nov 7, 1:35 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target +124.1% upside

Low Target $43.31

Average Target $63.84

High Target $68.31

Current Price $28.49

Current
$28.49

Target
$63.84

$43.31 $63.84 avg $68.31

Scenario Analysis

Bear Case

$43.31

52.0%

Low target

Base Case

$63.84

+124.1%

Avg target

Bull Case

$68.31

+139.8%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$34.29

-16.9% from high

52-Week Low

$13.18

+116.2% from low

50-Day SMA

$21.97

+29.7% vs SMA

200-Day SMA

$21.62

+31.8% vs SMA

RSI (14)

86.1

Overbought

Target vs 52W High

$63.84

+86.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%